ArticleAnnals of surgical oncology2026

A Percentage of Residual Viable Tumor Outperforms Traditional AJCC Staging in Oral Squamous Cell Carcinoma After Neoadjuvant Immunochemotherapy.

Yunli Fan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.